Clinical CDK2 Inhibitors: Trends to Selectivity and Efficacy | Bentham Science Publishers

2000

Volume 18, Issue 2

ISSN: 1574-8928
E-ISSN: 2212-3970

s Clinical CDK2 Inhibitors: Trends to Selectivity and Efficacy
By Polina V. Rusina, Alexey A. Lisov, Alexandra A. Denisova, Erik R. Gandalipov, Fedor N. Novikov and Alexander A. Shtil
Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 18, Issue 2, May 2023, p. 102 - 107
DOI: https://doi.org/10.2174/1574892817666220617091700
- Available online: 01 May 2023

Preview this article:

There is no abstract available.

© Bentham Science Publishers

Article metrics loading...

/content/journals/pra/10.2174/1574892817666220617091700

2023-05-01

2025-01-10

From This Site

/content/journals/pra/10.2174/1574892817666220617091700

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

/content/journals/pra/10.2174/1574892817666220617091700

Article Type: Other

Keyword(s): cancer; catalytic domain; CDK2; clinical trials; inhibitors; serine-threonine protein kinase

Most Cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test